Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07134426 · ClinicalTrials.gov registry record · NA
Vaped Phenanthrene
A NA study, sponsored by University of Minnesota.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07134426 is a NA study that has not yet begun recruiting, run by University of Minnesota. The registered enrollment target is 100 participants.
The verdict
NCT07134426, a NA study, has not yet begun recruiting, sponsored by University of Minnesota.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Some people who used to smoke cigarettes continue to be at higher risk of developing lung cancer, even years after quitting. This study will look to see if a specific chemical, phenanthrene, is broken down in the lungs of former smokers through more harmful pathways than never-smokers. If former smokers break down chemicals that enter their lungs through more harmful pathways this might be putting them at higher risk for developing lung cancer even though they quit smoking. This information may help find better ways to prevent or treat cancer in the future. This study is under an IND, but the drug is not being studied; instead, it is being used as a marker for drug metabolism.
Interventions
- OTHER D10-phenanthrene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-07-27 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07134426
The ClinicalTrials.gov registry entry for NCT07134426 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which D10-phenanthrene is the first listed.
NCT07134426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07134426 about?
NCT07134426 is a clinical study titled "Vaped Phenanthrene". Some people who used to smoke cigarettes continue to be at higher risk of developing lung cancer, even years after quitting. This study will look to see if a specific chemical, phenanthrene, is broken down in the lungs of former smokers through more harmful pathways than never-smokers. If former smo...
What is the current status of trial NCT07134426?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-07-27. Estimated completion is 2028-06-30.
What interventions are being tested in trial NCT07134426?
The interventions under investigation include: D10-phenanthrene (OTHER).
Who is sponsoring clinical trial NCT07134426?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.